Why this mRNA cancer vaccine is raising new treatment hope
Moderna and Merck said a personalized mRNA cancer vaccine reduced the risk of melanoma recurrence and spread in a late-stage trial, sending Moderna shares soaring as much as 160%.
#News #Reuters #Newsfeed #mRNA #Moderna #Merck #CancerVaccine
Read the story here: https://reut.rs/4qo2JEc
👉 Subscribe: https://reut.rs/4b8fRGn
Keep up with the latest news from around the world: https://www.reuters.com/
Follow Reuters on Facebook: https://www.facebook.com/Reuters
Follow Reuters on X: https://twitter.com/Reuters
Follow Reuters on Instagram: https://www.instagram.com/reuters/?hl=en
